An Open-label, Phase 2 Study of ACP-196 (Acalabrutinib) in Subjects With Mantle Cell Lymphoma

Research Site, Brussels

Research Site, Brussels

Research Site, Sydney

Research Site, Boston

Research Site, Wodonga

Research Site, Liège

Research Site, Yvoir

Research Site, Bruges

Research Site, Badalona

Research Site, New York

Research Site, Caen

Research Site, Milan

Research Site, Dijon

Research Site, Novara

Research Site, Pamplona

Research Site, Toulouse

Research Site, Pessac

Research Site, Tampa

Research Site, Montpellier

Research Site, Rennes

Research Site, Tours

Research Site, Grenoble

Research Site, Bologna

Research Site, Saint-Priest-en-Jarez

Research Site, Nantes

Research Site, Meldola

Research Site, Angers

Research Site, Vandœuvre-lès-Nancy

Research Site, Lille

Research Site, Chicago

Research Site, Niles

Research Site, Peoria

Research Site, Clermond Ferrand

Research Site, Strasbourg

Research Site, Pierre-Bénite

Research Site, Paris

Research Site, Paris

Research Site, Rouen

Research Site, Houston

Research Site, La Roche - Sure-Yon

Research Site, Créteil

Research Site, Seattle

Research Site, Hackensack

Research Site, Monash

Research Site, Prague

Research Site, Amsterdam

Research Site, Maastricht

Research Site, Rotterdam

Research Site, Krakow

Research Site, Lodz

Research Site, Olsztyn

Research Site, Cardiff

Research Site, Leeds

Research Site, Leicester

Research Site, Nottingham

Research Site, Oxford

Research Site, Plymouth

Research Site, Southampton